01 gosmanov pt video dr 2.18.14
TRANSCRIPT
![Page 1: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/1.jpg)
Patient Video
Dr. Gosmanov
01 Gosmanov Pt Video dr 2.18.14.pptx
![Page 2: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/2.jpg)
Patient Case (webinar)
• New patient, recently relocated
• 55 year old male
• BMI = 31
• HbA1c = 11.2
• Other labs
– Kidney function? Is this an issue for the patient?
–
–
Narrated by Dr. G in webinar format
![Page 3: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/3.jpg)
Patient Case (webinar)
• Physical exam
–
–
–
• Medications
–
–
–
Narrated by Dr. G in webinar format
![Page 4: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/4.jpg)
Patient Case (webinar)
• Medical history–
–
• Social history–
–
• Family history–
–
Narrated by Dr. G in webinar format
![Page 5: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/5.jpg)
Assessing the Patient: Stages of Change
(end of webinar section)
• Pre-contemplation (Avoidance/denial)
• Contemplation
• Preparation/Determination
• Action/Willpower
• Maintenance
Prochaska JO, et al. J Consult Clin Psychol. 1983;51(3):390-395.
![Page 6: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/6.jpg)
Meeting the Patient Readiness to Change (Patient Video: 5’)
• First interaction with patient
• Assessment of readiness to change
• Why are you here?
![Page 7: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/7.jpg)
Assessing the Patient: Stages of Change
(beginning of 2nd webinar section)
• Pre-contemplation (Avoidance/denial)
• Contemplation
• Preparation/Determination
• Action/Willpower
• Maintenance
Prochaska JO, et al. J Consult Clin Psychol. 1983;51(3):390-395.
![Page 8: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/8.jpg)
What is this approach to this patient? (webinar)
• Review patient interaction • Current status
– Readiness to change – Clinical presentation– History
• Review of risk/benefit– Diabetes complications– CV risk
• Goals– ABCs– Weight
• Strategy
![Page 9: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/9.jpg)
Type 2 Diabetes Risk Assessment
http://www.diabetes.org/are-you-at-risk/diabetes-risk-test/. Accessed February 2014.
![Page 10: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/10.jpg)
Heart Attack Risk Assessment
http://cvdrisk.nhlbi.nih.gov/. Accessed February 2014.
Factor
Age years
Gender O Female O Male
Total cholesterol mg/dl
HDL cholesterol mg/dl
Smoker O No O Yes
Systolic BP mmHg
Current hypertension medication?
O No O Yes
10-Year Risk of Heart Attack
![Page 11: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/11.jpg)
![Page 12: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/12.jpg)
Stroke Risk Assessment1. Are you a female and over the age of 55, OR are you male and over the age of 45? YES NO
2. Do you have high blood pressure, or do you take medication for high blood pressure?
(Ideal Blood Pressure is 120/80) YES NO
Your Blood Pressure: _________________ Date Tested: _________________
3. Do you smoke or have a long history of smoking? YES NO
4. Do you have an irregular heartbeat? YES NO Don’t Know
5. Do you have high cholesterol, OR do you take medication for high cholesterol? YES NO Don’t Know
6. Cholesterol Levels (if known) HDL: ________ LDL:______ Total:_________
Date Tested: ______________
7. Has your mother, father, siblings, or children had a stroke or heart disease? YES NO
8. Do you exercise less than 3 times per week for 20-30 minutes at a time? YES NO
9. Do you eat a diet high in saturated and/or animal fat? YES NO
10. Are you diabetic? YES NO
11. Are you overweight by 20 pounds or more? YES NO
www.hopeheart.org. Accessed February 2014.
3 or more “YES” see your doctor
![Page 13: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/13.jpg)
Treatment Goals: ABCs
• HbA1C
– < 7 % for many people
– Preprandial capillary plasma glucose 70–130 mg/dl
– Peak postprandial (1-2 hours) capillary plasma glucose < 180 mg/dl
• Blood pressure (mmHg)
– Systolic < 140 for most people
– Diastolic < 80 (< 90 per Joint National Committee-8 2014 guideline)
Inzucchi SE, et al. Diabetes Care. 2012;35(6):1364-1379. http://ndep.nih.gov/publications/PublicationDetail.aspx?PubId=114. Accessed Nov 2013.James PA, et al. JAMA. 2013 Dec 18. [Epub ahead of print]. http://jama.jamanetwork.com. Accessed Dec 2013.American Diabetes Association. Diabetes Care. 2014; 37:S14-S80.
![Page 14: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/14.jpg)
• Cholesterol – Lipid Profile (mg/dl)
– LDL Cholesterol < 100
LDL < 70 with overt CVD
– HDL Cholesterol Men > 40, Women > 50
– Triglycerides < 150
Inzucchi SE, et al. Diabetes Care. 2012;35(6):1364-1379. http://ndep.nih.gov/publications/PublicationDetail.aspx?PubId=114. Accessed Nov 2013.James PA, et al. JAMA. 2013 Dec 18. [Epub ahead of print]. http://jama.jamanetwork.com. Accessed Dec 2013.American Diabetes Association. Diabetes Care. 2014; 37:S14-S80.
Treatment Goals: ABCs(cont.)
![Page 15: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/15.jpg)
Diabetes Patients at Goal
Stark Casagrande S, et al. Diabetes Care. 2013;36(8):2271-2279. Ali MK, et al. N Engl J Med. 2013;368(17):1613-1624.
HbA1c 52%
LDL 56%
BP 51%
All 3 19%
![Page 16: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/16.jpg)
Other Risk Factors(end webinar section)
• Smoking
• Sedentary lifestyle
Education Must Be Ongoing
![Page 17: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/17.jpg)
Overview of Current Medical Condition (Patient Video—20’ for section?)
• Diabetes complications
– Consequences of continuing current path
• Diabetes comorbidities
• ABCs (current vs goal?)
– HbA1c
– BP
– Cholesterol
– BMI
![Page 18: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/18.jpg)
Risk Assessment (Patient Video)
• Myocardial infarction
• Stroke
• Amputation
• Blindness
• Loss of limb
![Page 19: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/19.jpg)
Action Plan(Patient Video, concluding initial visit)
• Review current patient condition
• Lifestyle changes, specific tools
• Medication changes
![Page 20: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/20.jpg)
?3-Month Follow-Up Visit (Patient Video)
• HbA1c change
• Body weight change?
• BP, lipids, etc.
• Self-reported lifestyle changes/smoking cessation
• Medication adherence
• AEs
• Solicit patient feedback on treatment plan
![Page 21: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/21.jpg)
Charting the Course (Patient Video)
• Reinforce positive accomplishments
• Review of risks in light of current values
• Areas for improvement
• Review of AEs
• Re-Assessing Goals
• Adjustments to medication?
• Set next visit
![Page 22: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/22.jpg)
Case Summary (webinar)
• Initial state
–
–
–
• Follow-up visit
– Improvements
– Challenges
• Next steps, likely course with this patient
![Page 23: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/23.jpg)
What Happened at the Patient Visits? (webinar)
• Readiness to change• Initial visit
– Exam– Lab values– Goals vs current –
• 3 month visit–
–
• Treatment plan for this patient
![Page 24: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/24.jpg)
ReduceHyperglycemia
MetforminInsulin
ThiazolidinedionesInsulin
GLP-1 analoguesDPP-4 inhibitors
SGLT2 InhibitorsInsulin
-glucosidaseinhibitors
SulfonylureasGlitinides
GLP = glucagon-like peptide;DPP = didpeptidyl peptidase
Multiple Therapies for Type 2 Diabetes
![Page 25: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/25.jpg)
Diabetes Drugs Impact Multiple Endpoints
Drug BWHyper-tension
Dys-lipidemia
Hypoglycemia Risk
-glucosidaseinhibitors
Neutral ImprovedNeutral/
ImprovedLow
DPP-4 inhibitors Loss/Neutral Neutral Improved Low
GLP-1 agonists Loss Improved Improved Low
Insulin Gain Neutral* Improved High
Meglitinides Gain Neutral Neutral Moderate
Metformin Loss/Neutral Neutral Improved Low
SGLT2 inhibitors Loss Improved ? Low
Sulfonylureas Gain Neutral Variable Moderate
TZD Gain Improved Improved Low
Basile JN. J Diabetes Complications. 2013;27(3):280-286.
*Hyperinsulinemia is associated with hypertension
![Page 26: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/26.jpg)
Therapeutic Options (webinar)
• Initial visit
– How did therapy match patient?
– Successes
– limitations
• Follow-up visit
– How was therapy adjusted?
– Expected impact
– Challenges
![Page 27: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/27.jpg)
What Do Patients Want to Know? (webinar)
• Benefits (long term avoidance of complications)
• Risks (short term adverse effects)– Weight gain
– Hypoglycemia
–
• Other issues– Injection anxiety
– Adherence
– Self-image?
– Cost/insurance
– Impact of ACA on diabetes care
![Page 28: 01 gosmanov pt video dr 2.18.14](https://reader033.vdocument.in/reader033/viewer/2022052508/559f6e921a28ab21068b460f/html5/thumbnails/28.jpg)
Key Messages (webinar)
•
•
•
•